Continuing our Life-Long Commitment to Rare Disease Patients Around the World
As our global community continues to navigate the impact of COVID-19, CENTOGENE remains fully open and operational, underlining our continued commitment to patients globally.
ORDER ON CENTOPORTAL®

Back
Img Alt Text

Transforming Global Genetic Data into Medical Decisions

We are a global leader in rare disease diagnosis and research by transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies

Rare Disease Day 2021

Join Us on 28 February
Rare Disease Day 2021!

Featuring our virtual conference on COVID-19 impacts and benefits of international diagnostic cooperation for patients all over the world.

Read More

Rare Disease Day 2021

Join Us on 28 February
Rare Disease Filmfestival 2021!

Watch our virtual festival of prize-winning films selected from 120 countries honoring and redefining what it means to be rare!

Read More

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

Customer Feedback

Give feedback

Newsletter subscription

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 22. Februar 2021

  • Epidemiologische Studie verfolgt das Ziel, das spezifische...
Weiterlesen

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 16. Februar 2021

  • Im Zuge der aufgetretenen SARS-CoV-2 Mutationen aus Großbritannien und Südafrika hat...
Weiterlesen

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 15. Februar 2021

  • Das Walk-In-Testzentrum an CENTOGENEs Firmenhauptsitz, am Strande 7 in Rostock, wird...
Weiterlesen

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 03. Februar 2021

  • CENTOGENE weitet sein SARS-CoV-2-Testangebot auf ein zweites Testzentrum in...
Weiterlesen

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 26. Januar 2021

  • Im Zuge der aufgetretenen SARS-CoV-2 Mutationen aus Großbritannien und Südafrika hat...
Weiterlesen

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 18. Januar 2021

  • Das Walk-In-Testzentrum im Flughafen Düsseldorf wurde vom Terminal C zur...
Weiterlesen

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 12. Januar 2021

  • Seit dem 11. Januar 2021 gilt bundesweit für Reiserückkehrer aus Risikogebieten...
Weiterlesen

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, December 18, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG) (“CENTOGENE” or the “Company”), a...

Weiterlesen

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 18. Dezember 2020

  • Der zentrale Standort des Testcenters erleichtert den Zugang zu zuverlässigen und...
Weiterlesen